The SNP was associated with the expression level of SYNE1, which in turn modulated HCC and TCC cell proliferation and migration, thereby affecting the clinical outcomes of patients with HCC alone or with HCC/TCC DPC. The gene discussed is SYNE1; the disease is hepatocellular carcinoma.